Document reference

2017/2822(DEA)  
Biocidal products: scientific criteria for the determination of endocrine-disrupting properties  
Basic information  

2017/2822(DEA)

DEA - Delegated acts procedure

Supplementing 2009/0076(COD)

Subject
3.70.13 Dangerous substances, toxic and radioactive wastes (storage, transport)
4.60.08 Safety of products and services, product liability

Status

Procedure completed - delegated act enters into force

 

Key players  
  • Committee responsible
    Rapporteur
    Appointed
    ENVI  
    Environment, Public Health and Food Safety
    (Associated committee)
    Committee for opinion
    Rapporteur for opinion
    Appointed
    IMCO  
    Internal Market and Consumer Protection
    (Associated committee)
Key events  
04/09/2017
Non-legislative basic document published
04/09/2017
Initial period for examining delegated act 2 month(s)
13/09/2017
Committee referral announced in Parliament, 1st reading/single reading
13/09/2017
Referral to associated committees announced in Parliament
17/10/2017
Delegated act not objected by Council
14/11/2017
Delegated act not objected by Parliament
Technical information  
Procedure reference
2017/2822(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/8/10938
Documentation gateway  
  • European Commission 
    Non-legislative basic document
     
    04/09/2017
    EC
     
    Document attached to the procedure
     
    C(2018)3067
    15/05/2018
    EC
     
    Document attached to the procedure
     
    C(2018)7828
    20/11/2018
    EC
     
  • All 
    Non-legislative basic document
       
    04/09/2017
    EC
     
    Document attached to the procedure
       
    C(2018)3067
    15/05/2018
    EC
     
    Document attached to the procedure
       
    C(2018)7828
    20/11/2018
    EC